亿胜生物科技（股票代码：01061）于2026年7月2日发布翌日披露报表，公告当日在香港联交所回购股份的最新进展。
本次公司于交易所场内回购35.00万股普通股，占本次事件前已发行股本（不包括库藏股）约0.06184%，每股回购价介乎2.50港元至2.61港元，合计耗资约89.55万港元。回购完成后，公司已发行股本（不包括库藏股）为565,650,000股，库藏股数增至1,356,000股，总股本保持在567,006,000股。公司于2026年5月26日通过购回授权，可回购最多56,700,600股；截至目前，已累计根据该授权在交易所购回1,356,000股，占当日已发行股本（不包括库藏股）约0.23915%。
公司确认上述回购事宜已按照香港联交所相关上市规则及 applicable 法律法规的规定进行，并获得董事会正式批准。公告由董事方海洲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.